What Malpractice Underwriters Won't Tell You About Your Group's Merger

Category: Malpractice Insurance Phase: Financial and Legal Aspects

A merger rarely changes who made the mistake. It changes who gets the bill.

I've watched physician groups celebrate a "clean transition" on Monday and discover three months later that the malpractice coverage protecting pre-merger care had a hole exactly where their old claims history fit. The acquisition closed. The EHR changed. The billing system changed. Then a delayed claim arrived, and the attorneys started asking which policy responded.

Here's the secret: malpractice insurance isn't a policy you buy once and file away. It's a chain of responsibility. A merger tests every link.

This article is for educational purposes only and is not financial advice, not legal advice, and not tax advice. Contract terms, carrier appetite, and figures vary by jurisdiction and policy; consult a qualified professional before approving any insurance or merger provision.

The Merger Mirage: What Nobody Mentions in the Boardroom

Everybody calls tail coverage a closing cost. That's their mistake, and yours if you repeat it.

Before finalizing any transition, it is helpful to understand how hospital lawyers actually use your malpractice policy against you during integration phases.

A tail is not a ceremonial line item. It determines who owns the long-tail consequences of care delivered before the transaction. It also determines who controls defense, who pays deductibles, how old claims are reported, and whether the selling physician can walk away from a case that emerges years later.

Let me be precise: a tail is not a "payout." It is a purchased continuation of reporting rights. Often the selling group buys an extended reporting period, or tail, for acts occurring during its policy period. Some policies also provide a limited basic extended reporting period when the insurer is canceled or the insured voluntarily surrenders the policy. That basic protection is not always equivalent to a full, purchased tail. The duration, scope, exclusions, and reporting mechanisms matter.

That makes tail coverage a strategic weapon. A buyer who assumes the seller will pay for unlimited legacy coverage gains immediate leverage. A seller who understands the tail can price it, cap it, shorten it, or transfer it. I've seen boards save six figures by refusing to sign an undefined promise that "the seller will obtain whatever tail is required."

Then comes the less obvious move: the underwriter gets to re-rate the entire merger.

A merger changes revenue, procedure mix, payer mix, location, physician ownership, and sometimes the relationship between employed physicians and the entity named on the policy. Those are legitimate underwriting inputs. But commercially, a merger also gives the carrier a fresh moment to reprice the book. The underwriter now knows your clinicians have a new owner, new systems, and new expectations. If any part of that environment increases reporting friction, claims may surface later.

Evaluating these costs is essential, particularly when unveiling malpractice insurance costs: a guide for physicians to ensure budget accuracy.

That's what "re-risking" means in practice: the merger resets assumptions, not necessarily the historical loss experience.

And then there is the "shadow history." That isn't one universal clause name. It's the boardroom shorthand for several connected realities: prior-acts language, loss-run reporting, indemnity, and allocation language can follow clinicians into the new group. A physician doesn't erase claims history by changing employers. The new carrier may receive the old group's loss runs. The seller may retain liability for pre-closing acts while the buyer receives the economic benefit of the transaction. The clinician may carry personal exposure that neither umbrella policy fully resolves.

That shadow history can be useful. It can also become a trap if the merger agreement never says who owns which claim.

The boardroom question should not be, "What will the new premium be?" It should be:

• Is every pre-closing act covered continuously?
• Which entity must report a delayed claim?
• Who pays the defense?
• Does the seller's indemnity survive closing?
• What happens when a clinician departs after the merger?

If leadership cannot answer those questions in plain English, the merger has an insurance gap disguised as a financing issue.

The Anatomy of a Claims-Made Trap

Claims-made coverage is easy to misunderstand. It doesn't simply mean "we cover everything that happened while the policy was active." Ordinarily, it covers qualifying claims made and reported during the policy period, subject to the retroactive date and other terms. A delayed claim reported after expiration may fall outside the policy even when the underlying procedure occurred while it was in force.

That is why continuity language deserves more attention than the premium.

"Continuity of coverage" has no uniform definition across policies. In one agreement, it may coordinate two successive policies. In another, it may require notice of cancellation, renewal, or a change in ownership. In still another, it may describe prior-acts coverage. The danger lies in the label. Boards assume it guarantees seamless protection when it may only describe how the carrier expects the transition to work.

Read the entire endorsement. Find the retroactive date. Identify every reporting deadline. Determine whether a cancellation notice triggers an extended reporting period, and whether that period is limited, conditional, or subject to premium payment.

Now look at prior acts.

Suppose your group had a difficult delivery case two years ago. A similar case, reported after the merger, emerges from the new system. If the new policy's retroactive date begins on the merger date, the pre-merger event falls outside its basic coverage. That doesn't end the seller's liability. It simply sends the claim somewhere else, or nowhere, if the tail wasn't bought correctly.

A prior-acts expansion may move the new policy's protection backward, but "moving the date" is not the whole deal. Underwriters may attach a higher retention, a sublimit, a specific exclusion, or different defense arrangements. They may exclude known incidents, reported matters, or matters reasonably expected to be reported. They may also retain the right to involve the seller's indemnity after a defense threshold is crossed.

This is the reserve-killing mistake: buying prior-acts protection without identifying the liabilities it picks up. A group can transform an old claim problem into a new balance-sheet problem simply by accepting the endorsement and never pricing the underlying exposure.

Consider a 12-physician obstetrics group acquired in early 2025. Its old policy has a retro date years earlier. A 2023 neonatal case was never reported because the family settled directly with the hospital. After the acquisition, the new carrier audits the records, learns of the matter, and treats it as pre-existing. The buyer's policy may exclude it. The seller's tail may not respond if the original carrier never received notice. The physician may face personal exposure, and the buyer may face indemnity claims. One unpriced sentence in the merger agreement now binds everyone.

Then come the administrative fees.

Post-merger adjustments can include carrier transition charges, loss-run fees, endorsement fees, risk-management services, minimum premiums, reporting-platform fees, and expenses associated with extended reporting. Some appear as separate line items. Others disappear into the base premium or a minimum-and-actual premium provision. The formula may look reasonable until you compare it with your historical quote.

Insurers have form templates. They also have a talent for burying changes in form templates. Demand the worksheet.

I don't care whether the fee is labeled "policy administration," "transition," or "risk management." If the dollar amount or percentage increased after the merger, it belongs in the board model next to the premium, retention, tail expense, and prior-acts cost. If it cannot be reconciled, it isn't an administrative detail. It's a repricing decision wearing a clerical label.

Negotiating with the House: How to Flip the Script

Here is the move most groups get backward: they let the malpractice carrier ride inside the larger insurance and integration workstream. The carrier becomes one more invoice in a closing checklist. Wrong. Malpractice coverage deserves its own negotiated workstream, its own exhibit, and its own decision gate before the final vote.

Never bundle the malpractice transition into the general merger agreement without a specific carve-out. "Insurance will remain in place through closing" is not enough. You need an insurance transition schedule stating:

• Which policy remains in force for each period and each entity.
• The retroactive date for every successor policy.
• Whether prior-acts coverage is purchased, and for which entity.
• Who buys and funds each tail.
• The reporting window for pre-closing acts.
• How defense costs, deductibles, and self-insured retentions are allocated.
• Which party must be notified before a claim is tendered.
• What happens when a physician retires, resigns, or dies.
• Which indemnity obligations survive closing.

I've seen a 38-physician surgical group avoid a painful post-close dispute because its attorney put a one-page insurance transition schedule behind the merger agreement. Two weeks later, one of its largest partners left. The schedule already required individual tail coverage and defined who paid. Without that page, the argument would have started with the first demand letter.

The chart below shows an illustrative pricing model, not a market benchmark or promise. It demonstrates why administrative and prior-acts charges deserve board-level attention.

The managed case isn't magic. It comes from defined exposures, accurate loss information, early carrier engagement, and separating transaction costs from premium. No insurer publishes a universal surcharge; actual pricing depends on the carrier, specialty mix, loss history, jurisdictions, limits, and appetite. Treat those percentages as a budgeting model only. Figures vary.

Now audit your loss runs before the underwriter audits you.

Request at least five years of loss experience when available. Review open and closed claims, incurred but unreported matters, never-reported events, tail claims, cancellations, policy changes, and relevant hospital or department events. Confirm the dates. Confirm the paid and incurred amounts. Confirm which claims were denied, reserved, or withdrawn. Check whether the carrier's history matches the representations in your purchase agreement.

Then do the thing most boards never does: reconcile the insurance schedule with the deal documents. If a material claim is missing from the seller's loss runs but appears in its financial statements, investigate. If a physician changed employers after a matter was reported, identify who managed the defense. If the buyer's indemnity escrow assumes one exposure and the carrier's quote assumes another, you have a gap.

You need three documents side by side:

1. The carrier's loss runs.
2. The merger's disclosure schedules and financial reserves.
3. The proposed insurance transition language.

Divergence in any two is a negotiation item, not a clerical annoyance.

Next, use collective leverage. Your group may have more leverage with the carrier than any individual physician believes. Specialty volume, clean loss history, claims expertise, and a credible alternative carrier matter. Bring your broker and independent counsel into the room with a specific ask, not "please lower the premium."

Ask for a componentized quote. Identify every administrative charge. Ask for prior-acts coverage in a separate endorsement with its own premium, retention, limits, and exclusions. Seek a fixed-cost tail proposal with a defined term. Request advance consent requirements before a carrier settles a legacy claim. Require notice when a limit or aggregate is exhausted.

Then negotiate a "sunset" for legacy exposure. In this context, a sunset means a defined reporting endpoint or a time-bounded allocation of legacy claims. It can mean a five- or seven-year tail rather than an unlimited one, a seller-paid obligation capped at a stated amount, or a buyer assumption of older claims subject to an agreed threshold. The right structure depends on the specialty. A short reporting period is easier to justify for a low-severity service than for emergency medicine, obstetrics, neurosurgery, or another long-tail specialty.

A sunset does not erase a claim already made, a notice already triggered, or a statutory reporting obligation. It controls how long and how broadly legacy exposure travels with the transaction.

Finally, preserve alternatives. A carrier that cannot provide continuous coverage, a full tail quote, and transparent prior-acts terms may not be the right home for the risk. "The market won't give us that" often means "we haven't asked a second carrier." Get competing proposals early, while the board still has leverage. A merger deadline is a weak reason to accept permanent coverage defects.

Protecting Your Personal License in a Corporate Shakeup

Malpractice coverage does not protect your license. Your license is an occupational privilege; coverage is a contractual promise to pay or defend qualifying claims. They are related, but they are not interchangeable.

A group umbrella may cover the corporation for vicarious liability and may protect physicians for acts within the policy's insured scope. Your employment agreement, professional services agreement, partnership agreement, and the policy itself determine where your personal liability ends. If you are an independent contractor, a partner, an owner, or a physician with outside activities, the group policy may not be enough.

"Additional insured" status is especially overused. It generally gives an additional party rights to enforce covered obligations or proceed directly against the insurer under applicable law. It does not automatically insure you personally. It does not create prior-acts coverage. It does not cover activities outside the policy's scope. And it does not replace an individual tail if you leave the group.

Consider the common trap: a partner leaves 90 days after the acquisition. A claim from care delivered at the old hospital is reported 18 months later. The buyer's policy excludes the pre-merger act. The seller's tail covers the entity, but the departing physician believes the new group still owes her a defense because it was "their" claim. Additional-insured language does not resolve that dispute. Personal exposure follows contractual indemnities, the tail, and the facts of the relationship.

Your career history must also be portable. Keep an individual claims-made policy when the role warrants one. If a policy ends, secure an individual tail with a documented reporting method. Preserve certificates, endorsements, claims correspondence, and proof of premium payment. Record which policy covered each period and which entity controlled each matter.

Don't confuse a certificate of insurance with protection. A certificate proves that a policy existed on a particular date. It does not reproduce the coverage, preserve your personal rights, or fix an excluded prior act.

The board should receive a separate personal-exposure analysis for each partner and senior clinician. Name the policy, the retroactive date, the limits, the defense trigger, the tail right, and the contractual indemnity. If the answer is "the group should handle it," push until the answer appears in a document.

Make the Liability Architecture Part of the Deal

The next merger will not be safer because the hospital market is friendlier or the purchase price is larger. It will be safer because somebody refuses to let insurance become an afterthought.

Before the final vote, demand the actual policies, endorsements, loss runs, tail proposal, and transition schedule. Make independent insurance counsel review the liability structure. Price the prior-acts exposure instead of hiding it. Give the tail a defined term and a defined payer. Then put the resulting obligations in the merger agreement.

If leadership understands the chain before closing, the merger becomes a transfer of opportunity. If it understands the chain afterward, the merger becomes a transfer of liability with a larger logo.